Resultados de la búsqueda 221-230 of 9629 for monoclonal antibody

  1. Oncología (médica) - Ensayos clínicos

    Monoclonal antibodies, such as obinutuzumab, may interfere with the ability of cancer cells to grow and spread. It is not yet known whether giving acalabrutinib ...

  2. Oncología (médica) - Ensayos clínicos

    Rituximab is a monoclonal antibody. It binds to a protein called CD20, which is found on B cells (a type of white blood cell) and some types of cancer cells ...

  3. Hematología - Ensayos clínicos - Mayo Clinic

    ... monoclonal antibody, and compare them with clinical outcomes. Registry for the EVolution Of LUng Cancer Therapy Implementation and Outcomes Now. Rochester ...

  4. Hematología - Ensayos clínicos

    Rituximab is a monoclonal antibody. It binds to a protein called CD20, which is found on B cells (a type of white blood cell) and some types of cancer cells ...

  5. Hematología - Ensayos clínicos

    Rituximab is a monoclonal antibody. It binds to a protein called CD20, which is found on B cells (a type of white blood cell) and some types of cancer cells ...

  6. Hematología - Ensayos clínicos

    Rituximab is a monoclonal antibody. It binds to a protein called CD20, which is found on B cells (a type of white blood cell) and some types of cancer cells ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Rituximab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. Venetoclax may stop the growth of cancer cells by ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Immunotherapy with monoclonal antibodies, such as pembrolizumab, may ... Rituximab is a monoclonal antibody. It binds to a protein called CD20, which ...

  9. Oncología (médica) - Ensayos clínicos

    Monoclonal antibodies, such as obinutuzumab, may interfere with the ability of cancer cells to grow and spread. It is not yet known whether giving acalabrutinib ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...